Literature DB >> 17822895

Pyrrolidinones as potent functional antagonists of the human melanocortin-4 receptor.

Wanlong Jiang1, Fabio C Tucci, Joe A Tran, Beth A Fleck, Jenny Wen, Stacy Markison, Dragan Marinkovic, Caroline W Chen, Melissa Arellano, Sam R Hoare, Michael Johns, Alan C Foster, John Saunders, Chen Chen.   

Abstract

A series of pyrrolidinones derived from phenylalaninepiperazines were synthesized and characterized as potent and selective antagonists of the melanocortin-4 receptor. In addition to their high binding affinities, these compounds displayed high functional potencies. 12a had a K(i) of 0.94 nM in binding and IC(50) of 21 nM in functional activity. 12a also demonstrated efficacy in a mouse cachexia model.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17822895     DOI: 10.1016/j.bmcl.2007.07.097

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  5 in total

1.  Solid-phase synthesis of N-substituted pyrrolidinone-tethered N-substituted piperidines via Ugi reaction.

Authors:  Zhang Liu; Adel Nefzi
Journal:  J Comb Chem       Date:  2010-07-12

Review 2.  The use of ghrelin and ghrelin receptor agonists as a treatment for animal models of disease: efficacy and mechanism.

Authors:  Mark D DeBoer
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

3.  Animal models of anorexia and cachexia.

Authors:  Mark Daniel Deboer
Journal:  Expert Opin Drug Discov       Date:  2009-11-01       Impact factor: 6.098

Review 4.  Update on melanocortin interventions for cachexia: progress toward clinical application.

Authors:  Mark Daniel DeBoer
Journal:  Nutrition       Date:  2009-12-08       Impact factor: 4.008

Review 5.  Pathophysiology of anorexia in the cancer cachexia syndrome.

Authors:  Chukwuemeka Charles Ezeoke; John E Morley
Journal:  J Cachexia Sarcopenia Muscle       Date:  2015-10-27       Impact factor: 12.910

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.